##gff-version 3
##sequence-region Q14542 1 456
Q14542	UniProtKB	Chain	1	456	.	.	.	ID=PRO_0000209340;Note=Equilibrative nucleoside transporter 2	
Q14542	UniProtKB	Transmembrane	13	33	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14542	UniProtKB	Transmembrane	70	90	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14542	UniProtKB	Transmembrane	99	119	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14542	UniProtKB	Transmembrane	124	144	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14542	UniProtKB	Transmembrane	162	182	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14542	UniProtKB	Transmembrane	193	213	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14542	UniProtKB	Transmembrane	291	311	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14542	UniProtKB	Transmembrane	324	344	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14542	UniProtKB	Transmembrane	360	380	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14542	UniProtKB	Transmembrane	386	406	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14542	UniProtKB	Transmembrane	432	452	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14542	UniProtKB	Modified residue	252	252	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692;Dbxref=PMID:20068231,PMID:21406692	
Q14542	UniProtKB	Glycosylation	48	48	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12590919;Dbxref=PMID:12590919	
Q14542	UniProtKB	Glycosylation	57	57	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12590919;Dbxref=PMID:12590919	
Q14542	UniProtKB	Glycosylation	225	225	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14542	UniProtKB	Alternative sequence	93	202	.	.	.	ID=VSP_040728;Note=In isoform 2. VPETVRILGSLLAILLLFALTAALVKVDMSPGPFFSITMASVCFINSFSAVLQGSLFGQLGTMPSTYSTLFLSGQGLAGIFAALAMLLSMASGVDAETSALGYFITPCVG->AGQGGHEPRTLLLHHHGLRLLHQLLQCSPTGQPLRAAGHHALHLQHPLPQRPGPGWDLCCPCHAPVHGQWRGRRDLCPGVLYHALCGHPHVHRVLPEPASPEVCPLLPGQ;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:7639753;Dbxref=PMID:7639753	
Q14542	UniProtKB	Alternative sequence	203	456	.	.	.	ID=VSP_040729;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:7639753;Dbxref=PMID:7639753	
Q14542	UniProtKB	Alternative sequence	290	301	.	.	.	ID=VSP_040730;Note=In isoform 3. IWLTALCLVLVF->SPCPSSPPSQPW;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:12527552;Dbxref=PMID:12527552	
Q14542	UniProtKB	Alternative sequence	302	456	.	.	.	ID=VSP_040731;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:12527552;Dbxref=PMID:12527552	
Q14542	UniProtKB	Natural variant	5	5	.	.	.	ID=VAR_029289;Note=D->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16214850;Dbxref=dbSNP:rs8187643,PMID:16214850	
Q14542	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_029290;Note=N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16214850;Dbxref=dbSNP:rs8187644,PMID:16214850	
Q14542	UniProtKB	Natural variant	94	94	.	.	.	ID=VAR_029291;Note=P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16214850;Dbxref=dbSNP:rs8187648,PMID:16214850	
Q14542	UniProtKB	Natural variant	184	186	.	.	.	ID=VAR_036822;Note=SGV->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16214850;Dbxref=PMID:16214850	
Q14542	UniProtKB	Mutagenesis	455	455	.	.	.	Note=Reduces drastically localization at the cell surface. No effect on uptake of adenosine and thymidine. Reduces drastically localization at the cell surface and induces an significant reduction of adenosine or thymidine uptake%3B when associated with R-456. L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12527552;Dbxref=PMID:12527552	
Q14542	UniProtKB	Mutagenesis	456	456	.	.	.	Note=Reduces drastically localization at the cell surface and induces an significant reduction of adenosine or thymidine uptake%3B when associated with R-455. L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12527552;Dbxref=PMID:12527552	
Q14542	UniProtKB	Sequence conflict	200	200	.	.	.	Note=C->Y;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q14542	UniProtKB	Sequence conflict	200	200	.	.	.	Note=C->Y;Ontology_term=ECO:0000305;evidence=ECO:0000305	
